by rss feed | Apr 16, 2024 | Investigative, News Feeds, RGCC, RGCC iPSC (CD34), SOT, supportive oligonucleotide therapy, VAX-Q-RE
I wrote a few weeks ago about a firm called RGCC or Research Genetic Cancer Center, which sells what I see as an unproven RNA therapy to clinics throughout the US. The approach is called supportive oligonucleotide therapy or SOT. After buying it from RGCC, the clinics...
by rss feed | Jan 24, 2024 | Chad Prodromos, Investigative, Kirk Cousins stem cells, News Feeds, Vitro Biopharma
It’s frustrating to see so much bad media coverage of celebrity trips to clinics to get supposed stem cell treatment of various kinds. Part of the concern here stems from ordinary people taking risks by following the example of the famous people. Good...
by rss feed | Sep 21, 2023 | BioBurst, Burst Biologics, Investigative, News Feeds, perinatal stem cells
The New York Times just broke a story on Burst Biologics and Weill Cornell that fits with long-standing troubling questions about regenerative biologics producers. The story also bears on the doctors and hospitals like Weill Cornell that were or are customers of the...
by rss feed | Apr 26, 2023 | assisted reproduction, in vitro gametogenesis, Investigative, IVF, News Feeds
Research on in vitro gametogenesis or IVG is jumping ahead and such work could one day lead to new infertility treatments. In vitro gametogenesis is the process of producing gametes (sperm and eggs) from stem cells. Those powerful stem cells, called iPS cells, can be...
by rss feed | Sep 13, 2022 | Direct Biologics, ExoFlo, FDA, Investigative, Linda Mays McCaul, Michael McCaul, News Feeds, Stephen Hahn
An FDA FOIA dump of text messages of former Commissioner Stephen Hahn suggests that a Texas regenerative firm called Direct Biologics benefited from political pressure on him in mid-2020. Then he was asked again to help in early 2021 shortly before he resigned at the...
